Kenya just became the second nation worldwide to eliminate the deadly, fast-acting rhodesiense form of sleeping sickness that kills within months if untreated.

Story Highlights

  • WHO validates Kenya as 10th country to eliminate sleeping sickness as public health problem
  • Second nation globally to conquer the acute rhodesiense form after Rwanda
  • Achievement follows decades of sustained surveillance and innovative oral treatments
  • Success builds on Kenya's 2018 Guinea worm disease elimination milestone

Historic WHO Validation Marks Continental Progress

The World Health Organization announced on August 8-9, 2025, that Kenya has successfully eliminated human African trypanosomiasis as a public health problem. This milestone places Kenya among only ten countries worldwide to achieve this status, with particular significance as the second nation to eliminate the rhodesiense form. WHO Director-General Tedros Adhanom Ghebreyesus declared this "another step toward making Africa free of neglected tropical diseases," highlighting Kenya's leadership in continental health security efforts.

Rhodesiense Form Presents Unique Elimination Challenge

Kenya's achievement stands apart because it conquered the rhodesiense variant of sleeping sickness, transmitted by tsetse flies in East and Southern Africa. Unlike the chronic gambiense form common in West and Central Africa, rhodesiense sleeping sickness progresses rapidly and proves fatal within months without treatment. The disease invades the central nervous system, causing severe neurological symptoms and sleep disturbances. This zoonotic form maintains animal reservoirs, making surveillance and vector control especially critical for preventing resurgence in rural agricultural communities.

Watch: Kenya declared free of sleeping sickness disease

Innovation and Partnerships Drive Success

Kenya's elimination success relied heavily on medical innovations that replaced toxic arsenic-based treatments with safer oral therapies. The Drugs for Neglected Diseases initiative played a crucial role in developing and scaling these improved treatments alongside enhanced diagnostic tools. These advances dramatically improved early detection capabilities and treatment feasibility in remote areas where rural populations engaged in agriculture, fishing, and animal husbandry faced highest exposure risks from tsetse fly ecology.

Economic Benefits Promise Rural Development Boost

Cabinet Secretary for Health Dr. Aden Duale emphasized the milestone will "pave the way for renewed economic growth and prosperity" through years of collaborative effort. The elimination reduces mortality burdens and healthcare costs for affected households while potentially boosting agricultural productivity and tourism in previously endemic regions. Rural communities now benefit from reduced disability burdens and improved school and work attendance. However, ongoing surveillance costs remain necessary to prevent disease resurgence, particularly given persistent zoonotic reservoirs.

Sustained Funding Critical for Long-term Success

Kenya must now maintain robust surveillance systems and rapid response capabilities to detect and manage any sporadic cases that emerge. The success demonstrates national capacity for multi-year disease control programs, building on Kenya's 2018 WHO certification for Guinea worm elimination. This track record positions Kenya as a regional leader in achieving WHO's goal for countries to eliminate at least one neglected tropical disease by 2030.

Sources:

Kenya eliminates sleeping sickness as public health problem

Kenya becomes 10th African nation to eliminate sleeping sickness

Statement on Kenya's elimination of rhodesiense sleeping sickness as public health problem

How Kenya fought for decades to eliminate a brain-attacking killer

Kenya eliminates sleeping sickness